1. Home
  2. OCS vs SPTN Comparison

OCS vs SPTN Comparison

Compare OCS & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • SPTN
  • Stock Information
  • Founded
  • OCS 2003
  • SPTN 1917
  • Country
  • OCS Switzerland
  • SPTN United States
  • Employees
  • OCS N/A
  • SPTN N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • SPTN Food Distributors
  • Sector
  • OCS Health Care
  • SPTN Consumer Discretionary
  • Exchange
  • OCS Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • OCS 717.3M
  • SPTN 746.4M
  • IPO Year
  • OCS N/A
  • SPTN N/A
  • Fundamental
  • Price
  • OCS $17.31
  • SPTN $19.52
  • Analyst Decision
  • OCS Strong Buy
  • SPTN Hold
  • Analyst Count
  • OCS 5
  • SPTN 1
  • Target Price
  • OCS $29.20
  • SPTN $20.00
  • AVG Volume (30 Days)
  • OCS 39.4K
  • SPTN 224.0K
  • Earning Date
  • OCS 11-07-2024
  • SPTN 02-13-2025
  • Dividend Yield
  • OCS N/A
  • SPTN 4.49%
  • EPS Growth
  • OCS N/A
  • SPTN 9.92
  • EPS
  • OCS N/A
  • SPTN 1.33
  • Revenue
  • OCS $1,027,571.00
  • SPTN $9,532,883,000.00
  • Revenue This Year
  • OCS $6.87
  • SPTN N/A
  • Revenue Next Year
  • OCS $884.16
  • SPTN $2.15
  • P/E Ratio
  • OCS N/A
  • SPTN $14.60
  • Revenue Growth
  • OCS N/A
  • SPTN N/A
  • 52 Week Low
  • OCS $10.11
  • SPTN $17.74
  • 52 Week High
  • OCS $18.00
  • SPTN $24.51
  • Technical
  • Relative Strength Index (RSI)
  • OCS 68.45
  • SPTN 50.14
  • Support Level
  • OCS $15.45
  • SPTN $19.19
  • Resistance Level
  • OCS $17.92
  • SPTN $19.77
  • Average True Range (ATR)
  • OCS 0.50
  • SPTN 0.44
  • MACD
  • OCS 0.17
  • SPTN 0.13
  • Stochastic Oscillator
  • OCS 81.42
  • SPTN 68.35

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: